Company Revenue

The company's orthopedic sale grew in the mid single digits during the second quarter as its transformation plan shows results....

The company's sales declined in the low single digits in the second quarter of 2024 amid a bevy of ongoing...

The company's orthopedic sales grew in the high single digits during the second quarter on healthy procedure volume and commercial...

The company celebrated its 25th anniversary with a world tour of scientific events and continued above-market growth in 2024's first...

The company continued its strong performance in 2024 with sales and regulatory wins, and now expects 2024 growth of more...

The company grew in the low single digits for the second quarter of 2024 but saw strong knee and hip...

The company leveraged it's differentiated and broad enabling technology ecosystem to drive implant and biologics sales growth....

The company grew in the low-single-digits in the first quarter of 2024 as supply and commercial struggles in the U.S....

The company's orthopedic sales grew more than 22% in 1Q24 as volume and staffing improve in the pediatric market....

The company's orthopedic sales grew in the mid-single-digits during 1Q24 as the company reduced headcount to control costs....